International Clinical Cytometry Society
New Strategies for Targeting CD38 in Multiple Myeloma Take Root
CD38, A Target for Immunotherapeutic Approaches in Cancer
CD38 - Wikipedia
CD38, A Target for Immunotherapeutic Approaches in Cancer
High‐Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action - Adams - 2019 - Cytometry Part A - Wiley Online Library
Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab | Leukemia
Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab | Leukemia
CD38 directed therapies for management of multiple myeloma | ITT
Comparison of CD38-Targeted α- Versus β-Radionuclide Therapy of Disseminated Multiple Myeloma in an Animal Model | Journal of Nuclear Medicine
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formatio
JCM | Free Full-Text | Resistance Mechanisms towards CD38−Directed Antibody Therapy in Multiple Myeloma
Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomes | SpringerLink
![Annotating CD38 Expression in Multiple Myeloma with [18F]F–Nb1053 | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.1c00733/asset/images/acs.molpharmaceut.1c00733.social.jpeg_v03 "Annotating CD38 Expression in Multiple Myeloma with [18F]F–Nb1053 | Molecular Pharmaceutics")
Annotating CD38 Expression in Multiple Myeloma with [18F]F–Nb1053 | Molecular Pharmaceutics
International Clinical Cytometry Society
Regulation of CD38 on Multiple Myeloma and NK Cells by Monoclonal Antibodies
CD38 expression and function in NK cells. (A) Role of CD38 in the... | Download Scientific Diagram
![PDF] Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/72ce80f2da87d037624955a597846d530a0c6052/3-Figure1-1.png "PDF] Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma | Semantic Scholar")
PDF] Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma | Semantic Scholar
Cureus | CD38: From Positive to Negative Expression after Daratumumab Treatment | Article
ePosters - Inecalcitol Stimulates CD38 Expression in Multiple Myeloma and Acute Myeloid Leukemia Cell Lines
Frontiers | CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
A Guide to Plasma Cell Markers | Biocompare: The Buyer's Guide for Life Scientists
The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implications - ScienceDirect
Detect CD38 expression during anti-CD38 therapy – Caltag Medsystems
